{"slug":"vip-diabetic-neuropathy","verification":{"valid":true,"entries":2,"head":"4fb3194d3dbde6d720cac3b5248ef67c48b3162dc2a0f64f9e6b46dc76d1babf"},"energy":{"passes":2,"tokens_in":14408,"tokens_out":1828,"tokens_total":16236,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"4fb3194d3dbde6d720cac3b5248ef67c48b3162dc2a0f64f9e6b46dc76d1babf"},"provenance":[{"ts":"2026-06-29T22:32:42.814Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Vip for Diabetic Neuropathy\nSlug: vip-diabetic-neuropathy\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Diabetic neuropathy\",\"condition_key\":\"diabetic-neuropathy\",\"primary_peptide\":\"vip\",\"peptides_in_scope\":[{\"id\":\"vip\",\"name\":\"VIP\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Diabetic neuropathy\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"vip\",\"name\":\"VIP\",\"section_title\":\"Why VIP might help you\",\"layer\":\"immune / autonomic\",\"steps\":[\"You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **VIP** → immune / autonomic\",\"section_headings\":[\"What's breaking down if you have Diabetic neuropathy\",\"Why VIP might help you\",\"How these fit together\",\"What the evidence ","response":"{\n  \"slug\": \"vip-diabetic-neuropathy\",\n  \"title\": \"VIP for Diabetic Neuropathy: Evidence-Graded Overview\",\n  \"body\": \"## What's breaking down if you have Diabetic neuropathy\\n\\nDiabetic neuropathy involves progressive nerve fiber damage linked to chronic high blood sugar. Layers include axonal degeneration, reduced nerve blood flow, immune activation in nerves, and autonomic imbalance. These processes shift the balance toward breakdown outrunning repair in peripheral nerves.\\n\\n## Why VIP might help you\\n\\n1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If the immune / autonomic layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nVIP has been studied for effects on nerve tissue repair pathways and autonomic signaling. If immune modulation or autonomic support aligns with the layers affected in your case, that forms the basis for discussion.\\n\\n## How these fit together\\n\\nSingle-compound focus. VIP targets the immune / autonomic layer listed in the condition profile.\\n\\n## What the evidence actually shows\\n\\nHuman data: One 1995 study measured VIP immunoreactivity in skin biopsies from diabetic patients with peripheral neuropathy and found reduced VIP levels in cutaneous nerves compared to controls (human observational). No randomized human trials of VIP administration for diabetic neuropathy were identified.\\n\\nPreclinical data: A rat study examined VIP levels during nerve regeneration and reported changes in immunoreactive VIP (preclinical). VIP showed anti-inflammatory effects in animal models of arthritis (preclinical).\\n\\nAnecdotal data: No direct Reddit or X reports specifically linking VIP use to diabetic neuropathy outcomes were found in searched results.\\n\\n## What scientists say\\n\\nReviews note VIP's roles in glucose-dependent insulin secretion and potential immune effects, but do not establish clinical use for neu","tokens_in":14408,"tokens_out":1828,"cost":0,"prev":"genesis","hash":"0199b89305b21b0093fa3e1a5db741d82fd8101a6c9eaed4649c6343326ba3c0"},{"ts":"2026-07-17T02:43:23.220Z","model":"owner","action":"voxel_divide","prompt":"","input":"vip-diabetic-neuropathy","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0199b89305b21b0093fa3e1a5db741d82fd8101a6c9eaed4649c6343326ba3c0","hash":"4fb3194d3dbde6d720cac3b5248ef67c48b3162dc2a0f64f9e6b46dc76d1babf"}]}